Elena Ratner - 13 Jan 2025 Form 4 Insider Report for Eterna Therapeutics Inc. (ERNA)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ERNA	Stock Option (Right to buy)	Award	$0	+140,078		$0.000000	140,078	13 Jan 2025	Common Stock	140,078	$0.3000	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The stock option shall vest over three years with 1/3 of the underlying shares vesting on the one-year anniversary of the grant date and the remaining underlying shares vesting in 24 substantially equal monthly installments thereafter.